Location: Home
  • search
  • go
  • Relate News
  • 10/21/2021Ligand and CR Double-Crane Enter Deal to Develop an Oral COVID-19 Ther...
  • 10/20/2021CStone Received Chinese IND Acceptance of lorlatinib for ROS1-posit...
  • 10/20/2021OliX, Pharmaron Agree to Advance Non-clinical Toxicology Testing for ...
  • 10/20/2021LianBio to Raise up to $345M in Planned IPO at Valuation of $1.8B
  • 10/20/2021COVID-19 Spurs Growth of China's Domestic Bioprocessing Suppliers: Bio...
  • 10/19/2021Chipscreen Secures Chinese Approval of Bilessglu (Chiglitazar Sodium t...
  • 10/19/2021Israel's Silenseed Inks $7.8M Deal with GIBF to Create Chinese JV
  • 10/19/2021Bridge Biotherapeutics Initiates Phase I Trial for Anti-inflammatory...
  • 10/19/2021Zai Lab and Entasis Announce Positive Topline Results for Sulbactam-Du...
  • 10/18/2021CDE Seeks Comments on Draft Chinese Translation of ICH Guideline Q13
  • 10/18/2021NHC Issues the 14th FYP for National Clinical Specialty Capacity Build...
  • 10/18/2021WuXi ATU Opens Fourth Manufacturing Facility
  • 10/18/2021I-Mab Granted IND Approval for P2 Trial of Efineptakin Alfa in Combo w...
  • 10/18/2021Innovent's P3 Study of Sintilimab for EGFR-Mutated Nonsquamous NSCLC ...
  • 10/18/2021Forbes: What Can We Learn From the Pharma Manufacturers Leaving China?
  • 10/15/2021PharmaDJ: September Fundraising Puts Cell Therapy and Immuno-Oncology ...
  • 10/15/2021CDE Issues the List of Reference Formulations for GQCE Studies (45th B...
  • 10/15/2021China Issues the Action Plan for Tumor Diagnosis and Treatment Quality...
  • 10/15/2021CDE Solicits Comments on the Draft Technical Guidelines for Pharmaceut...
  • 10/15/2021State Council Issues the Implementation Opinion for Promotion of Sanmi...
  • 10/15/2021Silence Therapeutics Inks Collaboration Deal with Hansoh Pharma
  • 10/15/2021Gan & Lee Concludes Phase 3 Studies of Biosimilar Insulin Glargine (G...
  • 10/15/2021Harbour Biomed Begins P3 Study of Hanall's HL161 (batoclimab)
  • 10/15/2021Bio-Thera Solutions Expands Partnership with Pharmapark in Russia and ...
  • 10/15/2021Akeso Advances Phase II Trial of IL-4R mAb (AK120) for Atopic Dermatit...
  • 10/15/2021Shanghai-based Abbisko Makes $200M+ Hong Kong Debut
  • 10/15/2021Adocia's Partner Tonghua Dongbao Cleared to Start Ultra-Rapid Insulin ...
  • 10/15/2021Recent Executive Moves
  • 10/15/2021Takeda Secures New Indication for Takecab as Maintenance Therapy of Re...
  • 10/14/2021CDE Issues the Technical Guidance for Clinical Research of Anti-HIV Dr...
  • Page:165/774 Total number of articles:23208: [First][<<] [163] [164] [165] [166] [167] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group